Publication | Closed Access

Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells

Mammalian TargetMedicineHormonal ReceptorProgesterone Receptor ExpressionGynecologyEndocrinologyPharmacologyEndometrial Cancer CellsCancer ResearchEndocrine-related Cancer